Novavax
- Market cap
- 1.85B
- P/E (TTM)i
- -8.31
- P/Bi
- -9.71
- EPSi
- 2.58
- Div yieldi
- 0.00%
- 52W posi
- 70%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 71.42% -0.03pp
- Institutions
- 308 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 41 buys · 6 sells
| Name | Role | Stake |
|---|---|---|
| John Jacobs | Chief Executive Officer | 0.19% |
| Elaine O'Hara | Chief Strategy Officer | 0.08% |
| James Kelly | Chief Financial Officer | 0.08% |
| John Trizzino | Executive VP, Chief Commercial Officer & Chief Business Officer | 0.07% |
| Mark Casey | Executive Vice President | 0.05% |
| David Mott | Independent Director | 0.05% |
| Richard Douglas | Independent Director | 0.04% |
| Gregg Alton | Independent Director | 0.03% |
| Richard Rodgers | Independent Director | 0.03% |
| Margaret McGlynn | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-19 | David Mott | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Richard Douglas | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Margaret McGlynn | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Gregg Alton | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Rachel King | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Richard Rodgers | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-17 | David Mott | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | David Mott | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Richard Douglas | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Richard Douglas | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Margaret McGlynn | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Margaret McGlynn | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Gregg Alton | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Gregg Alton | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Rachel King | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Rachel King | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Richard Rodgers | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Richard Rodgers | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | John Shiver | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | John Shiver | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:39:33 · For reference only, not investment advice and not tailored to your situation.